An interview with Dr Beverley Isherwood.
Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia | Psychedelic Invest
SARASOTA, FL, June 07, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug